DERMOSCRIBE SEBORRHEIC DERMATITIS (DERMOSCRIBE PTY LTD)
Welcome to the PulseAid listing for the DERMOSCRIBE SEBORRHEIC DERMATITIS drug offered from DERMOSCRIBE PTY LTD. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | DERMOSCRIBE PTY LTD |
NON-PROPRIETARY NAME: | SULFUR, SALICYLIC ACID, HYDROCORTISONE |
SUBSTANCE NAME: | SULFUR; SALICYLIC ACID; HYDROCORTISONE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2015-03-23 |
END MARKETING DATE: | 0000-00-00 |
DERMOSCRIBE SEBORRHEIC DERMATITIS HUMAN OTC DRUG Details:
Item Description | DERMOSCRIBE SEBORRHEIC DERMATITIS from DERMOSCRIBE PTY LTD |
LABELER NAME: | DERMOSCRIBE PTY LTD |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; 3; 1(g/100g; g/100g; g/100g) |
START MARKETING DATE: | 2015-03-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69683-202_bd427c73-c412-449e-9bd6-bd1326ad7f8e |
PRODUCT NDC: | 69683-202 |
APPLICATION NUMBER: | part348 |
Other SULFUR; SALICYLIC ACID; HYDROCORTISONE Pharmaceutical Manufacturers / Labelers: